SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-002094
Filing Date
2022-04-06
Accepted
2022-04-06 14:11:13
Documents
20
Period of Report
2022-03-31
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ivbt_8k.htm   iXBRL 8-K 23979
2 CERTIFICATE OF AMENDMENT TO CERTIFICATE ivbt_ex31.htm EX-3.1 2227
3 PRESS RELEASE ivbt_ex991.htm EX-99.1 12567
9 ivbt_ex31img3.jpg GRAPHIC 158829
10 ivbt_ex31img2.jpg GRAPHIC 175006
11 ivbt_ex991img1.jpg GRAPHIC 5269
12 ivbt_ex31img1.jpg GRAPHIC 129246
  Complete submission text file 0001477932-22-002094.txt   798153

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gmvp-20220331.xsd EX-101.SCH 5842
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gmvp-20220331_lab.xml EX-101.LAB 13249
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gmvp-20220331_cal.xml EX-101.CAL 906
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gmvp-20220331_pre.xml EX-101.PRE 8338
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gmvp-20220331_def.xml EX-101.DEF 2111
14 EXTRACTED XBRL INSTANCE DOCUMENT ivbt_8k_htm.xml XML 3288
Mailing Address 40 WALL STREET, SUITE 2701 NEW YORK NY 10005
Business Address 40 WALL STREET, SUITE 2701 NEW YORK NY 10005 640-380-1923
Innovation1 Biotech Inc. (Filer) CIK: 0001629205 (see all company filings)

IRS No.: 822275255 | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-55852 | Film No.: 22810252
SIC: 2834 Pharmaceutical Preparations